Press Releases Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform September, 24, 2020 Mason Miller Read More
Press Releases Monte Rosa exits stealth mode with $32.5 million Series A commitment from Versant Ventures and NEA May, 26, 2020 Mason Miller Read More